[Problem of reduction of DPN (diphosphopyridine nucleotide) concentration in tumors by cytostatics].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003067:Coenzymes; D054697:Cytostatic Agents; D009243:NAD; D009369:Neoplasms; D009374:Neoplasms, Experimental
D000970:Antineoplastic Agents; D003067:Coenzymes; D054697:Cytostatic Agents; D009243:NAD
COENZYMES; CYTOTOXIC DRUGS/effects; NEOPLASMS/experimental
J Natl Cancer Inst. 1956 Aug;17 (2):145-54
13357935
Klin Wochenschr. 1957 Dec 1;35(23):1163-6
13515158
Biochim Biophys Acta. 1953 Feb;10(2):256-67
13051402
Medizinische. 1956 Apr 14;(15):576-81
13321465
Hoppe Seylers Z Physiol Chem. 1954;297(1):1-18
13221258
Biochem J. 1949;45(3):337-42
15392861
Biochem Z. 1958;330(1):59-72
13535617
J Natl Cancer Inst. 1955 Aug;16(1):31-9
13243111
Biochem Z. 1956;328(3):163-75
13373824
Cancer Res. 1951 Nov;11(11):855-63
14886935
Klin Wochenschr. 1957 Nov 15;35(22):1102-5
13515145
J Biol Chem. 1948 Nov;176(2):665-77
18889922
Klin Wochenschr. 1955 May 1;33(17-18):409-19
14392834
Klin Wochenschr. 1958 Jul 15;36(14):677-8
13576742
Zur Frage der Erniedrigung der DPN-(Diphosphopyridinnucleotid-) Konzentration in Tumoren durch Cytostatica.